Location History:
- Fayetteville, AR (US) (2013 - 2015)
- Rogers, AR (US) (2015 - 2021)
Company Filing History:
14 out of 836 
10 out of 1,245 
2 out of 108 
Years Active: 2013-2021
Title: Sherryll Layton: Innovator in Vaccine Development
Introduction
Sherryll Layton is a prominent inventor based in Rogers, AR (US). She has made significant contributions to the field of immunology, particularly in the development of vaccine vectors aimed at enhancing immune responses to enteric pathogens. With a total of 14 patents to her name, Layton's work is at the forefront of innovative vaccine research.
Latest Patents
Among her latest patents, Layton has developed compositions and methods for enhancing immune responses to enteric pathogens. One notable patent involves vaccine vectors capable of eliciting an immune response to enteric bacteria. These vectors include a polynucleotide encoding a PAL polypeptide, which may be expressed on the surface of the vaccine vector. Additionally, the vaccine vector may incorporate a second polypeptide encoding an immunostimulatory polypeptide, such as a CD154 polypeptide or an HMGB1 polypeptide. Another significant patent focuses on vaccine vectors and methods to reduce Campylobacter infection. This innovation includes a first polynucleotide that encodes an antigenic polypeptide selected from specific sequences, along with methods for administering these vaccine vectors to enhance resistance to infection.
Career Highlights
Sherryll Layton has had a distinguished career, working with esteemed institutions such as the University of Arkansas and Texas A&M University System. Her research has not only advanced scientific understanding but has also contributed to practical applications in vaccine development.
Collaborations
Throughout her career, Layton has collaborated with notable colleagues, including Billy M. Hargis and Luc Berghman. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Sherryll Layton's contributions to vaccine development and immunology are invaluable. Her innovative patents and collaborations highlight her commitment to enhancing public health through scientific research.